R&D Partners

03/04/2025

📣 Top Jobs!

Our client is for several Quality Control roles in Philadelphia Metro Area!

:
✅ Quality Control Supervisor, Microbiology
✅ Quality Control Manager, Microbiology
✅ Senior QC Analyst, Microbiology
✅ Senior QC Analyst

02/25/2025

📣 Top Scientific Jobs!

R&D Partners is seeking to hire a Quality Control Analyst II, Sterility Assurance in Philadelphia.

: https://jobs.r-dpartners.com/index.smpl?arg=jb_details&POST_ID=12297730&pre=1

Your main responsibilities as a QC Analyst II:
✅ Assist with the development of sterility assurance principles at the site in the areas of aseptic processing, and contamination control.
✅ Assist with the design of the contamination control strategy.
✅ Perform gap/risk assessments EM programs in response to regulatory updates (i.e., EU Annex 1)
✅ Develop EMPQ strategy and provides oversight of the EM testing program for regulatory compliance.

02/24/2025

Top Jobs! 📣

R&D Partners is seeking to hire a Project Coordinator (Medical Affairs) in Irvine, California.

Apply Today: https://jobs.r-dpartners.com/index.smpl?arg=jb_details&POST_ID=12290866&pre=1

Your main responsibilities as a Project Coordinator (Medical Affairs):
✅ Provide administrative support to the Medical Affairs Department including expense reporting, document processing, data verification and quality control, training record audits and related projects.

02/24/2025

Top Jobs! 📣

R&D Partners is seeking to hire a Medical Reviewer in Cambridge, Massachusetts.

email your resume to Amy Pollack-Miller:
📩 [email protected]

Job Description:
☑️ The Medical Reviewer role is to perform medical case review and to provide expertise on all aspects of it with emphasis on harmonization of medical review approach.
☑️ This role will interface across all levels and functional areas of GPSRM and partner with the clinical development as well as Data Management teams.
☑️ The exceptional candidate that we seek will have an excellent medical judgment, strong analytical skills, understanding of lifecycle of drug safety and a flexible, hands-on nature with a high sense of urgency.
☑️ Collaborate with other pharmacovigilance colleagues to align on a harmonized approach to identifying, evaluating, and communicating safety issues.
☑️ Identify topics for escalation and collaborate with safety product leads to investigate potential safety signals.

02/07/2025

A recent survey by PPD - Pharmaceutical revealed that 35% of companies are increasingly turning to Functional Service Providers (FSPs). With a projected growth rate of over 8.68% from 2024 to 2032, FSPs are leading the charge. At R&D Partners, we offer you the expertise to navigate the FSP model with our 200+ years of combined industry experience. We specialize in sourcing top talent across Scientific, Clinical Research, and Engineering fields, tailored to your project needs.

Want to know if the FSP model is right for you? Check out our latest article to find out more https://www.r-dpartners.com/2024/05/07/the-rising-traction-and-market-share-of-the-fsp-model/

01/27/2025

This month, we’re excited to celebrate Senior Clinical Staffing Specialist, Renee Anglum, as she reaches an incredible milestone — 10 years with R&D Partners!

Renee’s unwavering dedication and hard work have not only been vital to our team's success but also to our partner's success. Her expertise in supporting businesses with their hiring needs is truly helping drive innovation and progress in our field. We are so thankful to have someone as talented and committed as Renee on our team. Here’s to many more years of shared success and growth!

01/22/2025

R&D Partners is seeking to hire a Data Analytics Leader in South San Francisco.

Your main responsibilities as a Data Analytics Leader:
✅ Collaborate closely with Risk Based Quality Management team members to operationalize the integrated Quality Risk Management Plan (iQRMP), and to manage the identification of critical-to-quality (CtQ) factors, development of risk control strategies, and implementation of risk mitigation activities
✅ Support study teams in selection, set up and maintenance of reports for Key Risk Indicators (KRIs), Quality Tolerance Limit parameters (QTLs), and other applicable assessments and dashboards, ensuring consistency by adopting applicable global standards
✅ Lead and perform peer reviews and QC of the ECD specific setup of KRIs and QTLs vs iQRMP and system specifications, as required.

: https://jobs.r-dpartners.com/index.smpl?arg=jb_details&POST_ID=12232936&pre=1

01/22/2025

Last week, the teams gathered in San Diego to celebrate the achievements from Q4 and look ahead to 2025.

Congratulations to everyone for their hard work and accomplishments! We celebrated a number of promotions and exceptional performances within the team, and we want to extend our gratitude to all of you for your efforts. Here’s to an exciting 2025!

01/16/2025

The healthcare and life sciences world is buzzing in San Francisco as over 500 companies present at this year’s J.P. Morgan Healthcare Conference. From AI innovations to updates on non-profit health systems and supply chain resilience, the event sets the stage for 2025.

Read the full article here: https://www.fiercehealthcare.com/providers/jpm25-here-are-companies-and-trends-were-watching

It's officially a new year for the healthcare industry, as biopharma and health sys | It's officially a new year for the healthcare industry, as biopharma and health system executives, investors, reporters and others make the annual trek to the Westin St. Francis in San Francisco for the J.P. Morgan...

01/13/2025

Facing a clinical trial deadline while juggling deliverables and team expansion?

Recruiting the right talent in life sciences can be challenging, especially under pressure. Our specialized recruiting services are designed to connect you with high calibre professionals who can help you meet deadlines, power growth, and drive your clinical trials forward.

Speak to our team today to learn more: https://www.r-dpartners.com/services/strategic-staffing/

01/09/2025

New Alzheimer’s drugs like Leqembi and Kisunla are creating buzz, but their true potential is not yet clear. While they show small improvements, some experts question if focusing on amyloid plaques—the hallmark of these treatments—is the right approach.

Read more about the debate: https://www.biospace.com/drug-development/amyloid-hypothesis-in-doubt-as-newly-approved-drugs-hit-hurdles

Even as Biogen and Eisai’s Leqembi and Eli Lilly’s Kisunla slowly roll out onto the market, experts question the efficacy of these anti-amyloid antibodies and the amyloid hypothesis overall.

01/07/2025

We excel in matching skilled professionals with top-tier opportunities in the life sciences sector. Leveraging our extensive network and tailored approach, you can be assured that you’ll be connected with talented professionals that align with your goals for 2025.

Speak to our team today if you are looking expand your team next year: https://www.r-dpartners.com/contact-new/